Getting the Best Results From CONCERTA® (Titration)
Because everyone has a unique response to ADHD medication, your doctor may need to adjust the dose of CONCERTA® to arrive at an optimal dose for your child. This adjustment is called "titration." Titration is used with many medications, including medication for blood pressure control, cholesterol management and others. And it's just as common in ADHD therapy. In fact, adjusting a child's ADHD medication in this way is supported by the American Academy of Pediatrics and may lead to more successful ADHD treatment.

Arriving at the optimal dose of ADHD medication

When your child begins CONCERTA® as a new medication therapy for ADHD, the doctor will prescribe a starting dose. If needed, your child's doctor may periodically increase this dose until symptoms are effectively under control.

This dosing titration may happen in the beginning of your child's ADHD medication therapy, or sometime later, as his or her needs change. Be sure to talk to your child's doctor about titration and follow his or her recommendations during this adjustment period. Together, you and your child can help the doctor arrive at the optimal dose.

It's important to keep track of your child's progress throughout ADHD therapy

Taking the time to chart progress in ADHD symptom management will greatly help your child's doctor or ADHD specialist decide whether or not to adjust the dose. Use this ADHD symptom-tracking sheet for a few weeks and then bring it with you to your child's next doctor visit. To download a FREE comprehensive symptom-tracking sheet, click here.

Dosage strengths

CONCERTA® is available in four dosage strengths - 18, 27, 36 and 54 mg tablets.

CONCERTA® is approved for doses up to 54 mg in children and 72 mg (two 36-mg tablets) in adolescents. CONCERTA can be used to treat ADHD in children and adolescents, and these dosing options allow the doctor to adjust your child's dose to effectively manage ADHD symptoms and any CONCERTA® side effects.

In clinical studies, over half of the patients were treated with doses of 36 or 54 mg of CONCERTA®.


NEXT STEPS: